Cardiogen
Peptide Bioregulator
Also known as Ala-Glu-Asp-Arg class peptide
Cardiogen is a short synthetic peptide of the bioregulator class, studied in research for tissue-specific activity in myocardial-tissue models.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Cardiogen is a short synthetic peptide of the bioregulator class, studied in research for tissue-specific activity in myocardial-tissue models.
Experimental models examine its influence on tissue development under controlled organotypic culture conditions.
Third-party tested for purity, ID, quantity.
Cardiogen is a short regulatory peptide investigated in organotypic tissue-culture research focused on myocardial tissue. Studies have examined synthetic peptide bioregulators and their effects on tissue development in culture.
The available literature is limited; research framing reflects the broader short-peptide-bioregulator field.
Cardiogen arises from research into tissue-specific short peptides proposed to influence myocardial-tissue cultures.
The published literature remains sparse and largely confined to organotypic culture investigations.
Research into Cardiogen is limited and centers on short-peptide regulation of myocardial-tissue development in culture models. Reference support is thin relative to better-studied compounds.
3 of the 3 areas below are addressed directly by a paper cited on this page.
Short-peptide bioregulator models
Addressed on this page by Zakutskiĭ 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Zakutskiĭ, AN. et al. (2006) — [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]
Myocardial tissue-culture research
Addressed on this page by Zakutskiĭ 2006, Chalisova 2009. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Zakutskiĭ, AN. et al. (2006) — [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]
- Chalisova, NI. et al. (2009) — [The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats]
Tissue-development signaling studies
Addressed on this page by Chalisova 2009, Zakutskiĭ 2006. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Chalisova, NI. et al. (2009) — [The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats]
- Zakutskiĭ, AN. et al. (2006) — [The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]
The references section of this page cites 2 primary papers published between 2006 and 2009 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Cardiogen, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Cardiogen is commonly described online in connection with faster healing from injury and improved recovery. In the research literature the same compound is filed under short-peptide bioregulator models, myocardial tissue-culture research and tissue-development signaling studies.
The 2 papers cited on this page, published between 2006 and 2009 (2 in animal models) describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Presented alongside compounds with decades of published research, as though the evidence base is comparable.
It is not. Cardiogen rests on 2 cited papers (between 2006 and 2009). A record that thin cannot support conclusions about mechanism, effect or safety, and the honest reading is that this compound has been studied very little rather than studied and validated.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Every lot of Cardiogen is independently assayed before it is released, and the certificate for the lot shipped is published rather than summarised. Where a certificate for a current lot is not yet posted, the lot has not yet been released against it.
Researchers who buy Cardiogen in the United States through Eppix Labs receive a batch-labelled vial whose certificate is published against that lot code, so the material can be matched to its analysis rather than to a generic specification.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Bacteriostatic water in most published protocols
- Format
- Lyophilized powder
Cardiogen is supplied as lyophilized powder. In the dry state the material is comparatively stable, which is why it ships at ambient temperature without a cold chain; once reconstituted it is a peptide in solution and the handling constraints tighten considerably. At 4 residues it is short enough to be produced by solid-phase synthesis, and the published sequence on this page is what an identity assay is checked against.
Repeated freeze-thaw cycling is the handling error most likely to degrade material of this class, because each cycle concentrates solutes at the ice boundary. Where a protocol calls for the same vial across multiple sessions, the published literature generally describes aliquoting after reconstitution rather than re-freezing the whole volume.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (20mg / Single Vial, 20mg / 5-Pack, 20mg / 10-Pack available), batch-labelled
- Batch documentation for the lot shipped, once its certificate is published
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of cardiogen. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
[The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats]
PubMed[The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats]
PubMedRelated
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
From$79.99
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$39.99
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$59.99
Long-acting amylin analog engineered for appetite signaling, metabolic control, and energy balance research
From$99.99